Cart
sales@molnova.com
Aurora Kinase Inhibitor III
CAS No. 879127-16-9
Aurora Kinase Inhibitor III( —— )
Catalog No. M20361 CAS No. 879127-16-9
Aurora kinase inhibitor III is a potent inhibitor of Aurora A kinase (IC50?= 42 nM).1?It is selective for Aurora A over BMX BTK IGF-1R c-Src TRKB SYK and EGFR.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 88 | In Stock |
|
| 5MG | 178 | In Stock |
|
| 10MG | 282 | In Stock |
|
| 25MG | 473 | In Stock |
|
| 50MG | 673 | In Stock |
|
| 100MG | 888 | In Stock |
|
| 200MG | 1242 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAurora Kinase Inhibitor III
-
NoteResearch use only, not for human use.
-
Brief DescriptionAurora kinase inhibitor III is a potent inhibitor of Aurora A kinase (IC50?= 42 nM).1?It is selective for Aurora A over BMX BTK IGF-1R c-Src TRKB SYK and EGFR.
-
DescriptionAurora kinase inhibitor III is a potent inhibitor of Aurora A kinase (IC50?= 42 nM).1?It is selective for Aurora A over BMX BTK IGF-1R c-Src TRKB SYK and EGFR.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAurora Kinase
-
RecptorAurora A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number879127-16-9
-
Formula Weight413.4
-
Molecular FormulaC21H18F3N5O?
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (120.9 mM)
-
SMILESFC(F)(F)c1cccc(Nc2ccnc(Nc3cccc(NC(=O)C4CC4)c3)n2)c1
-
Chemical NameN-[3-[[4-[[3-(trifluoromethyl)phenyl]amino]-2-pyrimidinyl]amino]phenyl]-cyclopropanecarboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang Q Liu Y Gao F et al. Discovery of EGFR Selective 46-Disubstituted Pyrimidines from a Combinatorial Kinase-Directed Heterocycle Library[J]. Journal of the American Chemical Society 2006 128(7):2182-2183.
molnova catalog
related products
-
CCT129202
CCT129202 is a potent, selective, ATP-competitive pan-Aurora kinase inhibitor with IC50 of 42, 198 and 227 nM for Aurora A, Aurora B and Aurora C, respectively.
-
GSK-1070916
A potent, selective and ATP-competitive inhibitor of Aurora B and C with Ki of 0.38 nM and 1.5 nM, respectively.
-
ENMD-2076
A multitargeted kinase inhibitor with IC50s of 3/14/23/40 nM for Flt3/Aurora A/Src/VEGFR2; also inhibits Aurora B, c-Kit, FGFR1 (IC50=100-350 nM).
